{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:28:59Z","timestamp":1789648139575,"version":"4.0.0"},"reference-count":67,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2024.12427","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T12:42:43Z","timestamp":1707914563000},"source":"Crossref","is-referenced-by-count":2,"title":["Role of microRNAs in cognitive decline related to COVID\u201119 (Review)"],"prefix":"10.3892","volume":"27","author":[{"given":"Anastasia","family":"Bougea","sequence":"first","affiliation":[{"name":"1st Department of Neurology, Eginition Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Georgakopoulou","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Laiko General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Lempesis","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Laiko General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Fotakopoulos","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, General University Hospital of Larissa, 41221 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Papalexis","sequence":"additional","affiliation":[{"name":"Unit of Endocrinology, First Department of Internal Medicine, Laiko General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pagona","family":"Sklapani","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Sismanogleio Hospital, 15126 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Trakas","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Sismanogleio Hospital, 15126 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetrios","family":"Spandidos","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Virology, School of Medicine, University of Crete, 71003 Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efthalia","family":"Angelopoulou","sequence":"additional","affiliation":[{"name":"1st Department of Neurology, Eginition Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2024,2,14]]},"reference":[{"issue":"482","key":"key20240314115605_b1-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2022.11409","article-title":"COVID-19-associated acute appendicitis in adults. A report of five cases and a review of the literature","volume":"24","author":"Georgakopoulou","year":"2022","journal-title":"Exp Ther Med"},{"key":"key20240314115605_b2-ETM-27-4-12427","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.sleep.2021.07.005","article-title":"COVID-19 associated nervous system manifestations","volume":"91","author":"Khatoon","year":"2022","journal-title":"Sleep Med"},{"key":"key20240314115605_b3-ETM-27-4-12427","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1002\/alz.12488","article-title":"Impact of COVID-19 on the onset and progression of Alzheimer's disease and related dementias: A roadmap for future research","volume":"18","author":"Gordon","year":"2022","journal-title":"Alzheimers Dement"},{"key":"key20240314115605_b4-ETM-27-4-12427","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1002\/acn3.51350","article-title":"Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 \u2018long haulers\u2019","volume":"8","author":"Graham","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"key20240314115605_b5-ETM-27-4-12427","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/alz.12255","article-title":"The chronic neuropsychiatric sequelae of COVID-19: The need for a prospective study of viral impact on brain functioning","volume":"17","author":"de Erausquin","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"110479","key":"key20240314115605_b6-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.110479","article-title":"Could COVID-19 anosmia and olfactory dysfunction trigger an increased risk of future dementia in patients with ApoE4?","volume":"147","author":"Manzo","year":"2021","journal-title":"Med Hypotheses"},{"issue":"1239182","key":"key20240314115605_b7-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1239182","article-title":"Cognitive impairment after long COVID-19: Current evidence and perspectives","volume":"14","author":"Li","year":"2023","journal-title":"Front Neurol"},{"key":"key20240314115605_b8-ETM-27-4-12427","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework","volume":"69","year":"2001","journal-title":"Clin Pharmacol Ther"},{"issue":"483","key":"key20240314115605_b9-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58040483","article-title":"MicroRNA as candidate biomarkers in atypical parkinsonian syndromes: Systematic literature review","volume":"58","author":"Bougea","year":"2022","journal-title":"Medicina (Kaunas)"},{"issue":"53","key":"key20240314115605_b10-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2014.00053","article-title":"Differential role of CSF alpha-synuclein species, tau, and A\u03b242 in Parkinson's disease","volume":"6","author":"Parnetti","year":"2014","journal-title":"Front Aging Neurosci"},{"issue":"e0151156","key":"key20240314115605_b11-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151156","article-title":"Abnormal Salivary Total and Oligomeric Alpha-Synuclein in Parkinson's Disease","volume":"11","author":"Vivacqua","year":"2016","journal-title":"PLoS One"},{"key":"key20240314115605_b12-ETM-27-4-12427","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1002\/mds.27110","article-title":"Diagnostic utility of cerebrospinal fluid \u03b1-synuclein in Parkinson's disease: A systematic review and meta-analysis","volume":"32","author":"Eusebi","year":"2017","journal-title":"Mov Disord"},{"key":"key20240314115605_b13-ETM-27-4-12427","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/bs.acc.2019.12.001","article-title":"New markers in Parkinson's disease","volume":"96","author":"Bougea","year":"2020","journal-title":"Adv Clin Chem"},{"key":"key20240314115605_b14-ETM-27-4-12427","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s00702-019-02062-4","article-title":"Salivary alpha-synuclein as a biomarker for Parkinson's disease: A systematic review","volume":"126","author":"Bougea","year":"2019","journal-title":"J Neural Transm (Vienna)"},{"issue":"78","key":"key20240314115605_b15-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-021-00775-x","article-title":"The role of noncoding RNAs in Parkinson's disease: Biomarkers and associations with pathogenic pathways","volume":"28","author":"Kuo","year":"2021","journal-title":"J Biomed Sci"},{"key":"key20240314115605_b16-ETM-27-4-12427","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41580-018-0045-7","article-title":"Regulation of microRNA function in animals","volume":"20","author":"Gebert","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20240314115605_b17-ETM-27-4-12427","doi-asserted-by":"publisher","first-page":"D155","DOI":"10.1093\/nar\/gky1141","article-title":"miRBase: From microRNA sequences to function","volume":"47(D1)","author":"Kozomara","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"key20240314115605_b18-ETM-27-4-12427","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s10571-019-00751-y","article-title":"Specific signatures of serum miRNAs as potential biomarkers to discriminate clinically similar neurodegenerative and vascular-related diseases","volume":"40","author":"Barbagallo","year":"2020","journal-title":"Cell Mol Neurobiol"},{"key":"key20240314115605_b19-ETM-27-4-12427","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3892\/or.2019.7215","article-title":"The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer's disease","volume":"42","author":"Candido","year":"2019","journal-title":"Oncol Rep"},{"issue":"5","key":"key20240314115605_b20-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2022.5208","article-title":"Role of non-coding RNAs as biomarkers and the application of omics technologies in Alzheimer's disease (Review)","volume":"51","author":"Pierouli","year":"2023","journal-title":"Int J Mol Med"},{"issue":"220","key":"key20240314115605_b21-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010220","article-title":"miRNAs as influencers of cell-cell communication in tumor microenvironment","volume":"9","author":"Conti","year":"2020","journal-title":"Cells"},{"key":"key20240314115605_b22-ETM-27-4-12427","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4103\/aian.AIAN_440_19","article-title":"Clinical application of circulating MicroRNAs in Parkinson's Disease: The challenges and opportunities as diagnostic biomarker","volume":"23","author":"Ramaswamy","year":"2020","journal-title":"Ann Indian Acad Neurol"},{"key":"key20240314115605_b23-ETM-27-4-12427","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1002\/acn3.51146","article-title":"Validation of differentially expressed brain-enriched microRNAs in the plasma of PD patients","volume":"7","author":"Ravanidis","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"issue":"625","key":"key20240314115605_b24-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00625","article-title":"Circulating miRNAs as diagnostic biomarkers for Parkinson's disease","volume":"12","author":"Roser","year":"2018","journal-title":"Front Neurosci"},{"key":"key20240314115605_b25-ETM-27-4-12427","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/mds.27928","article-title":"Circulating Brain-enriched MicroRNAs for detection and discrimination of idiopathic and genetic Parkinson's disease","volume":"35","author":"Ravanidis","year":"2020","journal-title":"Mov Disord"},{"key":"key20240314115605_b26-ETM-27-4-12427","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/ana.25490","article-title":"Meta-analyses identify differentially expressed micrornas in Parkinson's disease","volume":"85","author":"Schulz","year":"2019","journal-title":"Ann Neurol"},{"issue":"n71","key":"key20240314115605_b27-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"1490","key":"key20240314115605_b28-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"key":"key20240314115605_b29-ETM-27-4-12427","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12031-015-0574-x","article-title":"The Effect of miR-132, miR-146a, and miR-155 on MRP8\/TLR4-Induced astrocyte-related inflammation","volume":"57","author":"Kong","year":"2015","journal-title":"J Mol Neurosci"},{"issue":"462","key":"key20240314115605_b30-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00462","article-title":"microRNA-146a Signaling in Alzheimer's Disease (AD) and Prion Disease (PrD)","volume":"11","author":"Lukiw","year":"2020","journal-title":"Front Neurol"},{"key":"key20240314115605_b31-ETM-27-4-12427","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.7150\/thno.53418","article-title":"MicroRNA-146a switches microglial phenotypes to resist the pathological processes and cognitive degradation of Alzheimer's disease","volume":"11","author":"Liang","year":"2021","journal-title":"Theranostics"},{"key":"key20240314115605_b32-ETM-27-4-12427","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.bbadis.2016.06.001","article-title":"Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?","volume":"1862","author":"Kumar","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"366","key":"key20240314115605_b33-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2019.00366","article-title":"miR-146a Plasma Levels Are Not Altered in Alzheimer's Disease but Correlate With Age and Illness Severity","volume":"11","author":"Maffioletti","year":"2020","journal-title":"Front Aging Neurosci"},{"issue":"110448","key":"key20240314115605_b34-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.110448","article-title":"Downregulation of microRNA-146a in diabetes, obesity and hypertension may contribute to severe COVID-19","volume":"146","author":"Roganovi\u0107","year":"2021","journal-title":"Med Hypotheses"},{"issue":"111413","key":"key20240314115605_b35-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2020.111413","article-title":"Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients","volume":"193","author":"Sabbatinelli","year":"2021","journal-title":"Mech Ageing Dev"},{"key":"key20240314115605_b36-ETM-27-4-12427","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.anndiagpath.2018.03.006","article-title":"microRNA 155 up regulation in the CNS is strongly correlated to Down's syndrome dementia","volume":"34","author":"Tili","year":"2018","journal-title":"Ann Diagn Pathol"},{"issue":"90","key":"key20240314115605_b37-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010090","article-title":"MiR-155: An important regulator of neuroinflammation","volume":"23","author":"Zingale","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"61","key":"key20240314115605_b38-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2015.00061","article-title":"miR-155 is involved in Alzheimer's disease by regulating T lymphocyte function","volume":"7","author":"Song","year":"2015","journal-title":"Front Aging Neurosci"},{"key":"key20240314115605_b39-ETM-27-4-12427","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s13311-018-0665-9","article-title":"Inhibition of miR-155 limits neuroinflammation and improves functional recovery after experimental traumatic brain injury in mice","volume":"16","author":"Henry","year":"2019","journal-title":"Neurotherapeutics"},{"key":"key20240314115605_b40-ETM-27-4-12427","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.dadm.2015.11.004","article-title":"MicroRNA deregulation and chemotaxis and phagocytosis impairment in Alzheimer's disease","volume":"3","author":"Guedes","year":"2015","journal-title":"Alzheimers Dement (Amst)"},{"issue":"117202","key":"key20240314115605_b41-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117202","article-title":"A hypothesis-generating scoping review of miRs identified in both multiple sclerosis and dementia, their protein targets, and miR signaling pathways","volume":"420","author":"Varma-Doyle","year":"2021","journal-title":"J Neurol Sci"},{"issue":"102354","key":"key20240314115605_b42-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2022.102354","article-title":"The expression patterns of MALAT-1, NEAT-1, THRIL, and miR-155-5p in the acute to the post-acute phase of COVID-19 disease","volume":"26","author":"Abbasi-Kolli","year":"2022","journal-title":"Braz J Infect Dis"},{"issue":"107641","key":"key20240314115605_b43-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107641","article-title":"Acute and post-acute phase of COVID-19: Analyzing expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and let-7b-3p in PBMC","volume":"97","author":"Donyavi","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"key20240314115605_b44-ETM-27-4-12427","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.pathol.2021.09.006","article-title":"Circulating plasma miR-155 is a potential biomarker for the detection of SARS-CoV-2 infection","volume":"54","author":"Haroun","year":"2022","journal-title":"Pathology"},{"issue":"734","key":"key20240314115605_b45-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.3390\/biom9110734","article-title":"Elevated Plasma microRNA-206 levels predict cognitive decline and progression to dementia from mild cognitive impairment","volume":"9","author":"Kenny","year":"2019","journal-title":"Biomolecules"},{"issue":"R78","key":"key20240314115605_b46-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2013-14-7-r78","article-title":"A blood based 12-miRNA signature of Alzheimer disease patients","volume":"14","author":"Leidinger","year":"2013","journal-title":"Genome Biol"},{"issue":"820","key":"key20240314115605_b47-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.12461","article-title":"Let-7b-5p promotes cell apoptosis in Parkinson's disease by targeting HMGA2","volume":"24","author":"Huang","year":"2021","journal-title":"Mol Med Rep"},{"issue":"22","key":"key20240314115605_b48-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-0799-4","article-title":"Microglial-derived miRNA let-7 and HMGB1 contribute to ethanol-induced neurotoxicity via TLR7","volume":"14","author":"Coleman","year":"2017","journal-title":"J Neuroinflammation"},{"key":"key20240314115605_b49-ETM-27-4-12427","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41366-021-00984-2","article-title":"Upregulated miR-200c is associated with downregulation of the functional receptor for severe acute respiratory syndrome coronavirus 2 ACE2 in individuals with obesity","volume":"46","author":"Bellae Papannarao","year":"2022","journal-title":"Int J Obes (Lond)"},{"issue":"104668","key":"key20240314115605_b50-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2021.104668","article-title":"Identifying molecular insight of synergistic complexities for SARS-CoV-2 infection with pre-existing type 2 diabetes","volume":"136","author":"Islam","year":"2021","journal-title":"Comput Biol Med"},{"issue":"625659","key":"key20240314115605_b51-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/625659","article-title":"Serum MicroRNA profiles serve as novel biomarkers for the diagnosis of Alzheimer's disease","volume":"2015","author":"Dong","year":"2015","journal-title":"Dis Markers"},{"key":"key20240314115605_b52-ETM-27-4-12427","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.omtn.2020.01.010","article-title":"miRNA-31 improves cognition and abolishes amyloid-\u03b2 pathology by targeting APP and BACE1 in an animal model of Alzheimer's disease","volume":"19","author":"Barros-Viegas","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"key":"key20240314115605_b53-ETM-27-4-12427","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.bja.2017.12.033","article-title":"Inhibition of RhoA reduces propofol-mediated growth cone collapse, axonal transport impairment, loss of synaptic connectivity, and behavioural deficits","volume":"120","author":"Pearn","year":"2018","journal-title":"Br J Anaesth"},{"key":"key20240314115605_b54-ETM-27-4-12427","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1007\/s00213-021-05936-2","article-title":"MicroRNA-31-3p\/RhoA signaling in the dorsal hippocampus modulates methamphetamine-induced conditioned place preference in mice","volume":"238","author":"Qian","year":"2021","journal-title":"Psychopharmacology (Berl)"},{"issue":"41","key":"key20240314115605_b55-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.3390\/v14010041","article-title":"miRNAs, from evolutionary junk to possible prognostic markers and therapeutic targets in COVID-19","volume":"14","author":"Bautista-Becerril","year":"2021","journal-title":"Viruses"},{"issue":"75","key":"key20240314115605_b56-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-021-00544-4","article-title":"The relative expression of miR-31, miR-29, miR-126, and miR-17 and their mRNA targets in the serum of COVID-19 patients with different grades during hospitalization","volume":"26","author":"Keikha","year":"2021","journal-title":"Eur J Med Res"},{"issue":"e1009759","key":"key20240314115605_b57-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009759","article-title":"Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection","volume":"17","author":"Farr","year":"2021","journal-title":"PLoS Pathog"},{"issue":"842288","key":"key20240314115605_b58-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.842288","article-title":"MicroRNA-21 Is a versatile regulator and potential treatment target in central nervous system disorders","volume":"15","author":"Bai","year":"2022","journal-title":"Front Mol Neurosci"},{"issue":"31","key":"key20240314115605_b59-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-019-0169-5","article-title":"Exploratory study on microRNA profiles from plasma-derived extracellular vesicles in Alzheimer's disease and dementia with Lewy bodies","volume":"8","author":"G\u00e1mez-Valero","year":"2019","journal-title":"Transl Neurodegener"},{"key":"key20240314115605_b60-ETM-27-4-12427","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/jmcb\/mjr007","article-title":"MicroRNAs in NF-kappaB signaling","volume":"3","author":"Ma","year":"2011","journal-title":"J Mol Cell Biol"},{"issue":"363","key":"key20240314115605_b61-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2530-0","article-title":"Extracellular vesicle-mediated transfer of miR-21-5p from mesenchymal stromal cells to neurons alleviates early brain injury to improve cognitive function via the PTEN\/Akt pathway after subarachnoid hemorrhage","volume":"11","author":"Gao","year":"2020","journal-title":"Cell Death Dis"},{"key":"key20240314115605_b62-ETM-27-4-12427","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.biopha.2018.02.043","article-title":"MiR-21 attenuates apoptosis-triggered by amyloid-\u03b2 via modulating PDCD4\/PI3K\/AKT\/GSK-3\u03b2 pathway in SH-SY5Y cells","volume":"101","author":"Feng","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"key20240314115605_b63-ETM-27-4-12427","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1007\/s10529-020-02915-z","article-title":"MicroRNA miR-212 regulates PDCD4 to attenuate A\u03b225-35-induced neurotoxicity via PI3K\/AKT signaling pathway in Alzheimer's disease","volume":"42","author":"Wang","year":"2020","journal-title":"Biotechnol Lett"},{"issue":"1882","key":"key20240314115605_b64-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.3390\/cells11121882","article-title":"MicroRNA networks in cognition and dementia","volume":"11","author":"Blount","year":"2022","journal-title":"Cells"},{"key":"key20240314115605_b65-ETM-27-4-12427","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1016\/j.nrleng.2023.05.002","article-title":"The miRNA neuroinflammatory biomarkers in COVID-19 patients with different severity of illness","volume":"38","author":"Keikha","year":"2023","journal-title":"Neurologia (Engl Ed)"},{"issue":"e200","key":"key20240314115605_b66-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.200","article-title":"The noncoding and coding transcriptional landscape of the peripheral immune response in patients with COVID-19","volume":"10","author":"Tang","year":"2020","journal-title":"Clin Transl Med"},{"issue":"e0235987","key":"key20240314115605_b67-ETM-27-4-12427","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0235987","article-title":"Integrative analysis of miRNA and mRNA sequencing data reveals potential regulatory mechanisms of ACE2 and TMPRSS2","volume":"15","author":"Nersisyan","year":"2020","journal-title":"PLoS One"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T09:56:19Z","timestamp":1710410179000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2024.12427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,14]]},"references-count":67,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,2,14]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2024.12427","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,14]]},"article-number":"139"}}